MRI Contrast Media Market Report 2024-2033: Size, Share, Growth, Trends, Analysis, Demand, Forecast, Mergers and Acquisitions

The new report published by The Business Research Company, titled ""MRI Contrast Media Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the MRI contrast media market size has grown exponentially in recent years. It will grow from $1.48 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 6%. The MRI contrast media market size is expected to see exponential growth in the next few years. It will grow to $1.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=14964&type=smp

Rising Cancer Cases Fueling Growth Of MRI Contrast Media Market
The rise in cancer cases is expected to propel the growth of the MRI contrast media market going forward. The rise in cancer cases is multifactorial, influenced by a combination of demographic, lifestyle, environmental, genetic, and healthcare-related factors. Contrast agents containing gadolinium-based compounds, when administered during MRI scans, enhance visualization by altering tissue magnetic properties, aiding in the detection, sizing, and characterization of tumors, as well as assessing their invasion into surrounding tissues. For instance, in February 2024, according to a report published by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the global estimated number of new cancer cases reached 20 million in 2022, resulting in 9.7 million deaths. This projections suggest a significant rise in cancer cases by 2050, with over 35 million new cases anticipated, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the rise in cancer cases is driving the growth of the MRI contrast media market.

Innovative Products Driving Advancements In MRI Contrast Media Market
Major companies operating in the MRI contrast media market are focusing on developing and distributing advanced products, such as macrocyclic gadolinium-based contrast agents (GBCA), to enhance the diagnostic capabilities and safety profile of MRI imaging procedures. A macrocyclic gadolinium-based contrast agent (GBCA) is a type of contrast agent used in medical imaging, particularly in magnetic resonance imaging (MRI). For instance, in February 2023, Guerbet, a France-based provider of MRI contrast media, launched the Elucirem (gadopiclenol) injection. The unique feature of Elucirem (gadopiclenol) injection lies in its highly stable macrocyclic gadolinium-based contrast agent (GBCA), which has the highest relaxivity in its class for MRI. This innovative formulation of gadopiclenol is particularly noteworthy for its ability to detect and visualize lesions with abnormal vascularity in various regions of the central nervous system (including the brain, spine, and associated tissues) as well as the body (encompassing the head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

The MRI contrast media market covered in this report is segmented -
1) By Product: Extracellular Contrast Agents, Blood-Pool Agent, Hepatobiliary Agents
2) By Application: Neurological Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Cancer Detection, Other Applications
3) By End-User: Hospitals, Diagnostic And Imaging Centers, Research Institutes, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=14964&type=discount

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd, Rege Imaging & Cine Films Private Limited, Polarean Inc.

Contents of the report:
1. Executive Summary
2. MRI Contrast Media Market Report Structure
3. MRI Contrast Media Market Trends And Strategies
4. MRI Contrast Media Market - Macro Economic Scenario
5. MRI Contrast Media Market Size And Growth
…..
27. MRI Contrast Media Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/mri-contrast-media-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.